Clinical Trial Update: A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the effect of taspoglutide on gastric emptying in patients with Type 2 diabetes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Taspoglutide (taspoglutide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED